Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 194

    1.

    Revisional hindfoot arthrodesis.

    Murphy LJ, Mendicino RW, Catanzariti AR.

    Clin Podiatr Med Surg. 2009 Jan;26(1):59-78. Review.PMID: 19121754 [PubMed - indexed for MEDLINE]Related articles

    2.

    Application of a constrained external fixator frame for treatment of a fixed equinus contracture.

    Mendicino RW, Murphy LJ, Maskill MP, Catanzariti AR, Penny H.

    J Foot Ankle Surg. 2008 Sep-Oct;47(5):468-75. Epub 2008 Jul 18.PMID: 18725130 [PubMed - indexed for MEDLINE]Related articles

    3.

    Transglutaminase 2 kinase activity facilitates protein kinase A-induced phosphorylation of retinoblastoma protein.

    Mishra S, Melino G, Murphy LJ.

    J Biol Chem. 2007 Jun 22;282(25):18108-15. Epub 2007 May 3.PMID: 17478427 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Ethnicity, insulin resistance, and inflammatory adipokines in women at high and low risk for vascular disease.

    Silha JV, Nyomba BL, Leslie WD, Murphy LJ.

    Diabetes Care. 2007 Feb;30(2):286-91.PMID: 17259496 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Prohibitin binds to C3 and enhances complement activation.

    Mishra S, Moulik S, Murphy LJ.

    Mol Immunol. 2007 Mar;44(8):1897-902. Epub 2006 Oct 30.PMID: 17070910 [PubMed - indexed for MEDLINE]Related articles

    7.

    Plasma adipokines and body composition in response to modest dietary manipulations in the mouse.

    Silha JV, Weiler HA, Murphy LJ.

    Obesity (Silver Spring). 2006 Aug;14(8):1320-9.PMID: 16988074 [PubMed - indexed for MEDLINE]Related articles

    8.

    Phosphorylation of transglutaminase 2 by PKA at Ser216 creates 14-3-3 binding sites.

    Mishra S, Murphy LJ.

    Biochem Biophys Res Commun. 2006 Sep 8;347(4):1166-70. Epub 2006 Jul 17.PMID: 16870138 [PubMed - indexed for MEDLINE]Related articles

    9.

    The Prohibitins: emerging roles in diverse functions.

    Mishra S, Murphy LC, Murphy LJ.

    J Cell Mol Med. 2006 Apr-Jun;10(2):353-63. Review.PMID: 16796804 [PubMed - indexed for MEDLINE]Related articles

    10.

    Canadian guidelines for the management of adult growth hormone deficiency.

    Ur E, Serri O, Legg K, Murphy LJ, Ezzat S.

    Clin Invest Med. 2006 Apr;29(2):83-90.PMID: 16737084 [PubMed - indexed for MEDLINE]Related articles

    11.

    Insulin-like growth factor-I: a treatment for type 2 diabetes revisited.

    Murphy LJ.

    Endocrinology. 2006 Jun;147(6):2616-8. No abstract available. PMID: 16707730 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Insulin-like growth factor (IGF) binding protein-3 attenuates prostate tumor growth by IGF-dependent and IGF-independent mechanisms.

    Silha JV, Sheppard PC, Mishra S, Gui Y, Schwartz J, Dodd JG, Murphy LJ.

    Endocrinology. 2006 May;147(5):2112-21. Epub 2006 Feb 9.PMID: 16469805 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Prohibitin attenuates insulin-stimulated glucose and fatty acid oxidation in adipose tissue by inhibition of pyruvate carboxylase.

    Vessal M, Mishra S, Moulik S, Murphy LJ.

    FEBS J. 2006 Feb;273(3):568-76.PMID: 16420480 [PubMed - indexed for MEDLINE]Related articles

    14.

    Phosphorylation of histones by tissue transglutaminase.

    Mishra S, Saleh A, Espino PS, Davie JR, Murphy LJ.

    J Biol Chem. 2006 Mar 3;281(9):5532-8. Epub 2006 Jan 4.PMID: 16407273 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Insulin-like growth factor binding proteins in development.

    Silha JV, Murphy LJ.

    Adv Exp Med Biol. 2005;567:55-89. Review.PMID: 16370136 [PubMed - indexed for MEDLINE]Related articles

    16.

    The p53 oncoprotein is a substrate for tissue transglutaminase kinase activity.

    Mishra S, Murphy LJ.

    Biochem Biophys Res Commun. 2006 Jan 13;339(2):726-30. Epub 2005 Nov 28.PMID: 16313886 [PubMed - indexed for MEDLINE]Related articles

    17.

    Inhaled insulin improves glycemic control when substituted for or added to oral combination therapy in type 2 diabetes: a randomized, controlled trial.

    Rosenstock J, Zinman B, Murphy LJ, Clement SC, Moore P, Bowering CK, Hendler R, Lan SP, Cefalu WT.

    Ann Intern Med. 2005 Oct 18;143(8):549-58.PMID: 16230721 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    The effects of the insulin-like growth factor-I aptamer, NBI-31772, on glucose homeostasis in the mouse.

    Silha JV, Murphy LJ.

    Can J Physiol Pharmacol. 2005 Jul;83(7):557-63.PMID: 16091781 [PubMed - indexed for MEDLINE]Related articles

    19.

    The effects of growth hormone status on circulating levels of vascular growth factors.

    Silha JV, Krsek M, Hana V, Marek J, Weiss V, Jezkova J, Rosicka M, Jarkovska Z, Murphy LJ.

    Clin Endocrinol (Oxf). 2005 Jul;63(1):79-86.PMID: 15963066 [PubMed - indexed for MEDLINE]Related articles

    20.

    Angiogenic factors are elevated in overweight and obese individuals.

    Silha JV, Krsek M, Sucharda P, Murphy LJ.

    Int J Obes (Lond). 2005 Nov;29(11):1308-14.PMID: 15953938 [PubMed - indexed for MEDLINE]Related articles

    21.

    Prohibitin: a potential target for new therapeutics.

    Mishra S, Murphy LC, Nyomba BL, Murphy LJ.

    Trends Mol Med. 2005 Apr;11(4):192-7. Review.PMID: 15823758 [PubMed - indexed for MEDLINE]Related articles

    22.

    Insulin-like growth factor binding protein-3 (IGFBP-3) localizes to and modulates proliferative epidermal keratinocytes in vivo.

    Edmondson SR, Thumiger SP, Kaur P, Loh B, Koelmeyer R, Li A, Silha JV, Murphy LJ, Wraight CJ, Werther GA.

    Br J Dermatol. 2005 Feb;152(2):225-30.PMID: 15727632 [PubMed - indexed for MEDLINE]Related articles

    23.

    The effects of insulin-like growth factor binding protein-3 (IGFBP-3) on T47D breast cancer cells enriched for IGFBP-3 binding sites.

    Mishra S, Murphy LJ.

    Mol Cell Biochem. 2004 Dec;267(1-2):83-9.PMID: 15663189 [PubMed - indexed for MEDLINE]Related articles

    24.

    Overexpression of gly56/gly80/gly81-mutant insulin-like growth factor-binding protein-3 in transgenic mice.

    Silha JV, Gui Y, Mishra S, Leckstrom A, Cohen P, Murphy LJ.

    Endocrinology. 2005 Mar;146(3):1523-31. Epub 2004 Nov 18.PMID: 15550509 [PubMed - indexed for MEDLINE]Related articlesFree article

    25.

    Sexual dimorphism and regulation of resistin, adiponectin, and leptin expression in the mouse.

    Gui Y, Silha JV, Murphy LJ.

    Obes Res. 2004 Sep;12(9):1481-91.PMID: 15483213 [PubMed - indexed for MEDLINE]Related articles

    26.

    Plasma resistin, leptin and adiponectin levels in non-diabetic and diabetic obese subjects.

    Silha JV, Krsek M, Skrha J, Sucharda P, Nyomba BL, Murphy LJ.

    Diabet Med. 2004 May;21(5):497-9. No abstract available. PMID: 15089799 [PubMed - indexed for MEDLINE]Related articles

    27.

    Serum resistin (FIZZ3) protein is increased in obese humans.

    Silha JV, Murphy LJ.

    J Clin Endocrinol Metab. 2004 Apr;89(4):1977; author reply 1977-8. No abstract available. PMID: 15070974 [PubMed - indexed for MEDLINE]Related articlesFree article

    28.

    Tissue transglutaminase has intrinsic kinase activity: identification of transglutaminase 2 as an insulin-like growth factor-binding protein-3 kinase.

    Mishra S, Murphy LJ.

    J Biol Chem. 2004 Jun 4;279(23):23863-8. Epub 2004 Apr 5.PMID: 15069073 [PubMed - indexed for MEDLINE]Related articlesFree article

    30.

    The effects of GH replacement in adult GH-deficient patients: changes in body composition without concomitant changes in the adipokines and insulin resistance.

    Hana V, Silha JV, Justova V, Lacinova Z, Stepan JJ, Murphy LJ.

    Clin Endocrinol (Oxf). 2004 Apr;60(4):442-50.PMID: 15049958 [PubMed - indexed for MEDLINE]Related articles

    31.

    Adipokine levels in Cushing's syndrome; elevated resistin levels in female patients with Cushing's syndrome.

    Krsek M, Silha JV, Jezková J, Hána V, Marek J, Weiss V, Stepán JJ, Murphy LJ.

    Clin Endocrinol (Oxf). 2004 Mar;60(3):350-7.PMID: 15009001 [PubMed - indexed for MEDLINE]Related articles

    33.

    The role of the insulin-like growth factors and their binding proteins in glucose homeostasis.

    Murphy LJ.

    Exp Diabesity Res. 2003 Oct-Dec;4(4):213-24. Review.PMID: 14668045 [PubMed - indexed for MEDLINE]Related articlesFree article

    34.

    Changes in adipokine expression during food deprivation in the mouse and the relationship to fasting-induced insulin resistance.

    Gui Y, Silha JV, Mishra S, Murphy LJ.

    Can J Physiol Pharmacol. 2003 Oct;81(10):979-85.PMID: 14608416 [PubMed - indexed for MEDLINE]Related articles

    35.

    Perturbations in bone formation and resorption in insulin-like growth factor binding protein-3 transgenic mice.

    Silha JV, Mishra S, Rosen CJ, Beamer WG, Turner RT, Powell DR, Murphy LJ.

    J Bone Miner Res. 2003 Oct;18(10):1834-41.PMID: 14584894 [PubMed - indexed for MEDLINE]Related articles

    36.

    Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance.

    Silha JV, Krsek M, Skrha JV, Sucharda P, Nyomba BL, Murphy LJ.

    Eur J Endocrinol. 2003 Oct;149(4):331-5.PMID: 14514348 [PubMed - indexed for MEDLINE]Related articlesFree article

    37.

    Interaction of insulin-like growth factor binding protein-3 with latent transforming growth factor-beta binding protein-1.

    Gui Y, Murphy LJ.

    Mol Cell Biochem. 2003 Aug;250(1-2):189-95.PMID: 12962157 [PubMed - indexed for MEDLINE]Related articles

    38.

    Phosphorylation of insulin-like growth factor (IGF) binding protein-3 by breast cancer cell membranes enhances IGF-I binding.

    Mishra S, Murphy LJ.

    Endocrinology. 2003 Sep;144(9):4042-50. Erratum in: Endocrinology. 2004 Jan;145(1):213. PMID: 12933678 [PubMed - indexed for MEDLINE]Related articlesFree article

    39.

    Perturbations in adiponectin, leptin and resistin levels in acromegaly: lack of correlation with insulin resistance.

    Silha JV, Krsek M, Hana V, Marek J, Jezkova J, Weiss V, Murphy LJ.

    Clin Endocrinol (Oxf). 2003 Jun;58(6):736-42.PMID: 12780751 [PubMed - indexed for MEDLINE]Related articles

    40.

    Sildenafil citrate for treatment of erectile dysfunction in men with type 1 diabetes: results of a randomized controlled trial.

    Stuckey BG, Jadzinsky MN, Murphy LJ, Montorsi F, Kadioglu A, Fraige F, Manzano P, Deerochanawong C.

    Diabetes Care. 2003 Feb;26(2):279-84.PMID: 12547849 [PubMed - indexed for MEDLINE]Related articlesFree article

    41.

    Acarbose in the treatment of elderly patients with type 2 diabetes.

    Josse RG, Chiasson JL, Ryan EA, Lau DC, Ross SA, Yale JF, Leiter LA, Maheux P, Tessier D, Wolever TM, Gerstein H, Rodger NW, Dornan JM, Murphy LJ, Rabasa-Lhoret R, Meneilly GS.

    Diabetes Res Clin Pract. 2003 Jan;59(1):37-42.PMID: 12482640 [PubMed - indexed for MEDLINE]Related articles

    42.

    Impaired glucose homeostasis in insulin-like growth factor-binding protein-3-transgenic mice.

    Silha JV, Gui Y, Murphy LJ.

    Am J Physiol Endocrinol Metab. 2002 Nov;283(5):E937-45.PMID: 12376320 [PubMed - indexed for MEDLINE]Related articlesFree article

    43.

    Insights from insulin-like growth factor binding protein transgenic mice.

    Silha JV, Murphy LJ.

    Endocrinology. 2002 Oct;143(10):3711-4. Review.PMID: 12239079 [PubMed - indexed for MEDLINE]Related articlesFree article

    44.

    The cost of self-monitoring of blood glucose is an important factor limiting glycemic control in diabetic patients.

    Nyomba BL, Berard L, Murphy LJ.

    Diabetes Care. 2002 Jul;25(7):1244-5. No abstract available. PMID: 12087028 [PubMed - indexed for MEDLINE]Related articlesFree article

    45.

    Overexpression of the acid-labile subunit of the IGF ternary complex in transgenic mice.

    Silha JV, Gui Y, Modric T, Suwanichkul A, Durham SK, Powell DR, Murphy LJ.

    Endocrinology. 2001 Oct;142(10):4305-13.PMID: 11564688 [PubMed - indexed for MEDLINE]Related articlesFree article

    47.

    Phenotypic manifestations of insulin-like growth factor-binding protein-3 overexpression in transgenic mice.

    Modric T, Silha JV, Shi Z, Gui Y, Suwanichkul A, Durham SK, Powell DR, Murphy LJ.

    Endocrinology. 2001 May;142(5):1958-67.PMID: 11316761 [PubMed - indexed for MEDLINE]Related articlesFree article

    48.

    Cloning of the mouse Pax4 gene promoter and identification of a pancreatic beta cell specific enhancer.

    Xu W, Murphy LJ.

    Mol Cell Endocrinol. 2000 Dec 22;170(1-2):79-89.PMID: 11162892 [PubMed - indexed for MEDLINE]Related articles

    49.

    Physiological differences in insulin-like growth factor binding protein-1 (IGFBP-1) phosphorylation in IGFBP-1 transgenic mice.

    Sakai K, D'Ercole AJ, Murphy LJ, Clemmons DR.

    Diabetes. 2001 Jan;50(1):32-8.PMID: 11147791 [PubMed - indexed for MEDLINE]Related articlesFree article

    50.

    Unexpected and unexplained phenotypes in transgenic models.

    Murphy LJ, Silha JV.

    Growth Horm IGF Res. 2000 Oct;10(5):233-5. No abstract available. PMID: 11042018 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...